These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 30076448

  • 1. Pharmacological properties of ASP7657, a novel, potent, and selective prostaglandin EP4 receptor antagonist.
    Mizukami K, Kamada H, Yoshida H, Ishii I, Nozawa E, Wada K, Ugawa T.
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1319-1326. PubMed ID: 30076448
    [Abstract] [Full Text] [Related]

  • 2. Renoprotective effects of the novel prostaglandin EP4 receptor-selective antagonist ASP7657 in 5/6 nephrectomized chronic kidney disease rats.
    Mizukami K, Yoshida H, Nozawa E, Wada K, Ugawa T.
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Apr; 392(4):451-459. PubMed ID: 30554341
    [Abstract] [Full Text] [Related]

  • 3. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
    Timoshenko AV, Xu G, Chakrabarti S, Lala PK, Chakraborty C.
    Exp Cell Res; 2003 Oct 01; 289(2):265-74. PubMed ID: 14499627
    [Abstract] [Full Text] [Related]

  • 4. Study on Physiological Roles of Stimulation of Prostaglandin E2 Receptor Subtype EP2 in Urethral Function in Rats.
    Kurihara R, Ishizu K, Takamatsu H, Yoshino T, Masuda N.
    Low Urin Tract Symptoms; 2016 May 01; 8(2):125-9. PubMed ID: 27111625
    [Abstract] [Full Text] [Related]

  • 5. Prostaglandin E2 receptors of the EP2 and EP4 subtypes downregulate tumor necrosis factor alpha-induced intercellular adhesion molecule-1 expression in human gingival fibroblasts.
    Noguchi K, Iwasaki K, Shitashige M, Ishikawa I.
    J Periodontal Res; 1999 Nov 01; 34(8):478-85. PubMed ID: 10697805
    [Abstract] [Full Text] [Related]

  • 6. Molecular cloning and functional characterization of the canine prostaglandin E2 receptor EP4 subtype.
    Castleberry TA, Lu B, Smock SL, Owen TA.
    Prostaglandins Other Lipid Mediat; 2001 Jul 01; 65(4):167-87. PubMed ID: 11444589
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug.
    Caselli G, Bonazzi A, Lanza M, Ferrari F, Maggioni D, Ferioli C, Giambelli R, Comi E, Zerbi S, Perrella M, Letari O, Di Luccio E, Colovic M, Persiani S, Zanelli T, Mennuni L, Piepoli T, Rovati LC.
    Arthritis Res Ther; 2018 Mar 01; 20(1):39. PubMed ID: 29490676
    [Abstract] [Full Text] [Related]

  • 8. The roles of prostaglandin E receptor subtypes in the cytoprotective action of prostaglandin E2 in rat stomach.
    Araki H, Ukawa H, Sugawa Y, Yagi K, Suzuki K, Takeuchi K.
    Aliment Pharmacol Ther; 2000 Apr 01; 14 Suppl 1():116-24. PubMed ID: 10807413
    [Abstract] [Full Text] [Related]

  • 9. PGE2 upregulates renin through E-prostanoid receptor 1 via PKC/cAMP/CREB pathway in M-1 cells.
    Gonzalez AA, Salinas-Parra N, Leach D, Navar LG, Prieto MC.
    Am J Physiol Renal Physiol; 2017 Oct 01; 313(4):F1038-F1049. PubMed ID: 28701311
    [Abstract] [Full Text] [Related]

  • 10. Possible involvement of brain prostaglandin E2 and prostanoid EP3 receptors in prostaglandin E2 glycerol ester-induced activation of central sympathetic outflow in the rat.
    Shimizu T, Tanaka K, Nakamura K, Taniuchi K, Yawata T, Higashi Y, Ueba T, Dimitriadis F, Shimizu S, Yokotani K, Saito M.
    Neuropharmacology; 2014 Jul 01; 82():19-27. PubMed ID: 24657150
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effect of prostaglandin E(2) on the migration of nasal fibroblasts.
    Shin JM, Park IH, Moon YM, Hong SM, Cho JS, Um JY, Lee HM.
    Am J Rhinol Allergy; 2014 Jul 01; 28(3):e120-4. PubMed ID: 24980222
    [Abstract] [Full Text] [Related]

  • 12. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
    Matsumoto S, Ikeda M, Yoshida S, Tanimoto T, Takeda M, Nasu M.
    Br J Pharmacol; 2005 Jun 01; 145(4):503-13. PubMed ID: 15821755
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK, Barnes PJ, Giembycz MA.
    Br J Pharmacol; 1997 Sep 01; 122(1):149-57. PubMed ID: 9298541
    [Abstract] [Full Text] [Related]

  • 14. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ, Gilbert M, Pullen N, Skerratt S, Farrington J, Seward EP, Peachell PT.
    Clin Exp Allergy; 2013 Jul 01; 43(7):741-51. PubMed ID: 23786281
    [Abstract] [Full Text] [Related]

  • 15. Contribution of the two Gs-coupled PGE2-receptors EP2-receptor and EP4-receptor to the inhibition by PGE2 of the LPS-induced TNFalpha-formation in Kupffer cells from EP2-or EP4-receptor-deficient mice. Pivotal role for the EP4-receptor in wild type Kupffer cells.
    Fennekohl A, Sugimoto Y, Segi E, Maruyama T, Ichikawa A, Püschel GP.
    J Hepatol; 2002 Mar 01; 36(3):328-34. PubMed ID: 11867175
    [Abstract] [Full Text] [Related]

  • 16. Expression of prostaglandin receptors EP4 and FP in human lens epithelial cells.
    Mukhopadhyay P, Bhattacherjee P, Andom T, Geoghegan TE, Andley UP, Paterson CA.
    Invest Ophthalmol Vis Sci; 1999 Jan 01; 40(1):105-12. PubMed ID: 9888433
    [Abstract] [Full Text] [Related]

  • 17. [Cooperation of two subtypes of PGE2 receptor, Gi coupled EP3 and Gs coupled EP2 or EP4 subtype].
    Hatae N.
    Yakugaku Zasshi; 2003 Oct 01; 123(10):837-43. PubMed ID: 14577329
    [Abstract] [Full Text] [Related]

  • 18. Differential regulation of airway smooth muscle cell migration by E-prostanoid receptor subtypes.
    Aso H, Ito S, Mori A, Suganuma N, Morioka M, Takahara N, Kondo M, Hasegawa Y.
    Am J Respir Cell Mol Biol; 2013 Mar 01; 48(3):322-9. PubMed ID: 23221043
    [Abstract] [Full Text] [Related]

  • 19. Activation of prostaglandin E2-receptor EP2 and EP4 pathways induces growth inhibition in human gastric carcinoma cell lines.
    Okuyama T, Ishihara S, Sato H, Rumi MA, Kawashima K, Miyaoka Y, Suetsugu H, Kazumori H, Cava CF, Kadowaki Y, Fukuda R, Kinoshita Y.
    J Lab Clin Med; 2002 Aug 01; 140(2):92-102. PubMed ID: 12228765
    [Abstract] [Full Text] [Related]

  • 20. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
    Säfholm J, Manson ML, Bood J, Delin I, Orre AC, Bergman P, Al-Ameri M, Dahlén SE, Adner M.
    J Allergy Clin Immunol; 2015 Nov 01; 136(5):1232-9.e1. PubMed ID: 25962903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.